214 related articles for article (PubMed ID: 34478730)
1. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
3. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
4. Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high-fat diet.
Yu T; Wang Y; Chen X; Xiong W; Tang Y; Lin L
J Cell Mol Med; 2020 Aug; 24(15):8603-8613. PubMed ID: 32633894
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
6. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
7. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
8. Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function.
Yu S; Jiang J; Li Q; Liu X; Wang Z; Yang L; Ding L
Front Cell Infect Microbiol; 2022; 12():855008. PubMed ID: 36132991
[TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
[TBL] [Abstract][Full Text] [Related]
10. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
11. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
[TBL] [Abstract][Full Text] [Related]
12.
Tian G; Wang W; Xia E; Chen W; Zhang S
Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
[TBL] [Abstract][Full Text] [Related]
13. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
[TBL] [Abstract][Full Text] [Related]
15. Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways.
Wu J; Shao H; Zhang J; Ying Y; Cheng Y; Zhao D; Dou X; Lv H; Li S; Liu F; Ling P
Int J Biol Macromol; 2019 Jun; 130():68-78. PubMed ID: 30797009
[TBL] [Abstract][Full Text] [Related]
16. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation.
Gao LL; Ma JM; Fan YN; Zhang YN; Ge R; Tao XJ; Zhang MW; Gao QH; Yang JJ
Int J Biol Macromol; 2021 Jul; 183():1379-1392. PubMed ID: 33992651
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis.
Sun WL; Yang JW; Dou HY; Li GQ; Li XY; Shen L; Ji HF
Bioorg Chem; 2021 Jul; 112():104966. PubMed ID: 33991837
[TBL] [Abstract][Full Text] [Related]
18. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA
Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
Front Immunol; 2021; 12():679897. PubMed ID: 34367139
[TBL] [Abstract][Full Text] [Related]
20. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.
Dai Y; Zhu W; Zhou J; Shen T
Braz J Med Biol Res; 2022; 55():e12096. PubMed ID: 35584453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]